Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Tyrvaya Nasal Pump with Silicone Lubricant
NCT06329687Phase 4Terminated
- Sponsor
- Oyster Point Pharma
- Start
- Feb 2024
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of varenicline in dry eye disease (DED), sponsored by Oyster Point Pharma. Primary endpoint: Number of Participants With Adverse Events at 7 days. Started Feb 2024; status: terminated.
02
Drugs
varenicline
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT06329687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06329687.